NewsBenzingaBarclays Maintains Overweight on CVS Health, Lowers Price Target to $107 Barclays Maintains Overweight on CVS Health, Lowers Price Target to $107 Benzinga 2026.11.05 18:34 (GMT+0) Open on Benzinga Other news Moody's and Chainlink Complete Testnet Pilot to Distribute Credit Ratings Cross-Chain Alta Closes $47.5M Series A Led by Index Ventures Anthropic Sets IPO Price Range at $70 to $78, Valuing Company at Up to $1.4 Trillion Adobe adds more AI to its products and launches an MCP New York Times: Oil Prices Are Just the Beginning as US Inflation Spreads to More Areas Anthropic sets IPO price range of $70 to $78 per share to reach an implied valuation of $1.404 trillion
Anthropic sets IPO price range of $70 to $78 per share to reach an implied valuation of $1.404 trillion
